Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).

BCG Vaccine / therapeutic use Betacoronavirus COVID-19 Coronavirus Infections / diagnosis Epidemics HIV Infections / diagnosis Humans Influenza A Virus, H1N1 Subtype Influenza, Human / diagnosis Lung / immunology Middle East Respiratory Syndrome Coronavirus Pandemics Pneumonia, Viral / diagnosis Public Health Respiratory Tract Infections / diagnosis SARS-CoV-2 Severe Acute Respiratory Syndrome / diagnosis Tuberculosis / diagnosis Virus Diseases / diagnosis

Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
10 2020
Historique:
received: 11 05 2020
accepted: 12 06 2020
pubmed: 27 6 2020
medline: 10 10 2020
entrez: 27 6 2020
Statut: epublish

Résumé

Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) remains the top infectious disease killer, but apart from syndemic TB/HIV little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors (excluding the ECDC PHE team) identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology and immunology of these viral infections and their interactions with TB are discussed with implications for diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.

Identifiants

DOI: 10.1183/13993003.01727-2020 PMID: 32586885 PMC: PMC7527651
pubmed: 32586885
pii: 13993003.01727-2020
doi: 10.1183/13993003.01727-2020
pmc: PMC7527651
pii:
doi:

Substances chimiques

BCG Vaccine 0

Types de publication

Consensus Development Conference Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright ©ERS 2020.

Déclaration de conflit d'intérêts

Conflict of interest: G.B. Migliori has nothing to disclose. Conflict of interest: M. Raviglione has nothing to disclose. Conflict of interest: G. MacGregor-Skinner has nothing to disclose. Conflict of interest: G. Sotgiu has nothing to disclose. Conflict of interest: J-W. Alffenaar has nothing to disclose. Conflict of interest: S. Tiberi has nothing to disclose. Conflict of interest: C. Adlhoch has nothing to disclose. Conflict of interest: T. Alonzi has nothing to disclose. Conflict of interest: S. Archuleta has nothing to disclose. Conflict of interest: S. Brusin has nothing to disclose. Conflict of interest: E. Cambau has nothing to disclose. Conflict of interest: M.R. Capobianchi has nothing to disclose. Conflict of interest: C. Castilletti has nothing to disclose. Conflict of interest: R. Centis has nothing to disclose. Conflict of interest: D.M. Cirillo has nothing to disclose. Conflict of interest: L. D'Ambrosio has nothing to disclose. Conflict of interest: G. Delogu has nothing to disclose. Conflict of interest: S.M.R. Esposito has nothing to disclose. Conflict of interest: J. Figueroa has nothing to disclose. Conflict of interest: J.S. Friedland has nothing to disclose. Conflict of interest: B.C.H. Ho has nothing to disclose. Conflict of interest: G. Ippolito has nothing to disclose. Conflict of interest: M. Jankovic has nothing to disclose. Conflict of interest: H.Y. Kim has nothing to disclose. Conflict of interest: S. Rosales Klintz has nothing to disclose. Conflict of interest: C. Ködmön has nothing to disclose. Conflict of interest: E. Lalle has nothing to disclose. Conflict of interest: Y.S. Leo has nothing to disclose. Conflict of interest: C-C. Leung has nothing to disclose. Conflict of interest: A-G. Märtson has nothing to disclose. Conflict of interest: M.G. Melazzini has nothing to disclose. Conflict of interest: S. Najafi Fard has nothing to disclose. Conflict of interest: P. Penttinen has nothing to disclose. Conflict of interest: L. Petrone has nothing to disclose. Conflict of interest: E. Petruccioli has nothing to disclose. Conflict of interest: E. Pontali has nothing to disclose. Conflict of interest: L. Saderi has nothing to disclose. Conflict of interest: M. Santin has nothing to disclose. Conflict of interest: A. Spanevello has nothing to disclose. Conflict of interest: R. van Crevel has nothing to disclose. Conflict of interest: M.J. van der Werf has nothing to disclose. Conflict of interest: D. Visca has nothing to disclose. Conflict of interest: M. Viveiros has nothing to disclose. Conflict of interest: J-P. Zellweger has nothing to disclose. Conflict of interest: A. Zumla has nothing to disclose. Conflict of interest: D. Goletti has nothing to disclose. Conflict of interest: C.W.M. Ong has nothing to disclose.

Références

Diagn Microbiol Infect Dis. 2013 Mar;75(3):277-81
pubmed: 23276770
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Antimicrob Agents Chemother. 2013 Apr;57(4):1743-55
pubmed: 23357765
Int J Infect Dis. 2012 May;16(5):e321-31
pubmed: 22387143
Eur Respir J. 2018 Nov 8;52(5):
pubmed: 30361242
J Rheumatol. 2013 Jun;40(6):768-80
pubmed: 23457383
J Antimicrob Chemother. 2016 Apr;71(4):1037-40
pubmed: 26747099
Semin Immunopathol. 2015 May;37(3):239-49
pubmed: 25917388
Lancet Public Health. 2020 May;5(5):e261-e270
pubmed: 32220655
Respirology. 2018 May;23(5):455-466
pubmed: 29457312
Open Forum Infect Dis. 2019 Mar 19;6(3):ofz020
pubmed: 30906797
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10961-6
pubmed: 18667699
N Engl J Med. 2015 Jul 30;373(5):415-27
pubmed: 26172429
PLoS Pathog. 2016 Jul 13;12(7):e1005760
pubmed: 27409590
Infect Dis Poverty. 2020 Apr 7;9(1):34
pubmed: 32264957
Drug Saf. 2018 Oct;41(10):919-931
pubmed: 29858838
Antiviral Res. 2014 Jul;107:84-94
pubmed: 24769245
Postgrad Med. 2019 Jun;131(5):299-308
pubmed: 30845866
JAMA. 2003 Jun 4;289(21):2801-9
pubmed: 12734147
Clin Rheumatol. 2007 Nov;26(11):1809-10
pubmed: 17594118
Clin Infect Dis. 2012 Dec;55(11):1532-49
pubmed: 22942202
Proc Am Thorac Soc. 2011 Jun;8(3):282-7
pubmed: 21653529
Exp Gerontol. 2018 Oct 1;111:35-44
pubmed: 29991459
Emerg Infect Dis. 2006 Apr;12(4):707-9
pubmed: 16715587
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Clin Infect Dis. 2014 Jul 15;59(2):160-5
pubmed: 24723278
Curr Opin Virol. 2013 Aug;3(4):468-74
pubmed: 23806514
Lancet Public Health. 2020 Apr;5(4):e188-e189
pubmed: 32197116
Bull World Health Organ. 2014 May 1;92(5):318-30
pubmed: 24839321
Autoimmun Rev. 2020 Jul;19(7):102568
pubmed: 32376398
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Clin Chest Med. 2017 Mar;38(1):1-9
pubmed: 28159152
J Occup Environ Med. 2004 Jul;46(7):613-22
pubmed: 15247800
Emerg Infect Dis. 2018 Mar;24(3):498-505
pubmed: 29460733
Lancet. 2020 Mar 21;395(10228):945
pubmed: 32142626
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
PLoS One. 2014 Jan 22;9(1):e84866
pubmed: 24465443
Hum Vaccin Immunother. 2012 Jan;8(1):17-20
pubmed: 22252002
J Chin Med Assoc. 2004 Nov;67(11):579-82
pubmed: 15720073
N Engl J Med. 2015 Feb 26;372(9):835-45
pubmed: 25714161
Clin Microbiol Infect. 2019 Dec;25(12):1473-1478
pubmed: 31055165
Eur Respir J. 2020 Jun 18;55(6):
pubmed: 32350103
Clin Pharmacokinet. 1996 Oct;31(4):257-74
pubmed: 8896943
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Pharmacol Ther. 2020 May;209:107512
pubmed: 32097670
Tuberculosis (Edinb). 2013 May;93(3):338-42
pubmed: 23474302
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Eur Respir J. 2020 May 21;55(5):
pubmed: 32341111
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
Pediatr Infect Dis J. 2013 Mar;32(3):e119-27
pubmed: 23099423
Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa105
pubmed: 32284951
Expert Rev Mol Med. 2011 Dec 16;13:e39
pubmed: 22172201
Biomed Pharmacother. 2019 Feb;110:440-448
pubmed: 30530046
PLoS Pathog. 2016 Jun 15;12(6):e1005687
pubmed: 27304615
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
PLoS One. 2014 Apr 16;9(4):e94949
pubmed: 24740417
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet HIV. 2018 Dec 6;:
pubmed: 30529029
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551
pubmed: 32112072
J Clin Virol. 2004 Jan;29(1):13-22
pubmed: 14675864
Crit Care. 2016 May 07;20(1):123
pubmed: 27153800
Respirology. 2003 Nov;8 Suppl:S6-8
pubmed: 15018126
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Emerg Infect Dis. 2004 May;10(5):782-8
pubmed: 15200809
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Epidemiol Infect. 2014 Oct;142(10):2036-48
pubmed: 24331081
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32205349
Clin Microbiol Infect. 2019 Jan;25(1):107.e1-107.e7
pubmed: 29581053
BMC Health Serv Res. 2018 Dec 17;18(1):973
pubmed: 30558670
PLoS One. 2016 Oct 5;11(10):e0162575
pubmed: 27706149
Semin Immunol. 2014 Dec;26(6):588-600
pubmed: 25458990
N Engl J Med. 2020 Apr 2;382(14):1370-1371
pubmed: 32163697
Lancet. 2020 Feb 15;395(10223):e30-e31
pubmed: 32032529
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
J Comp Pathol. 2014 Jul;151(1):83-112
pubmed: 24581932
J Infect. 2020 Jul;81(1):e1-e5
pubmed: 32171872
Int J STD AIDS. 2005 Feb;16(2):95-100; quiz 101
pubmed: 15807935
MMWR Morb Mortal Wkly Rep. 2014 Sep 12;63(36):798-9
pubmed: 25211545
J Pharm Pharmacol. 2013 Apr;65(4):521-7
pubmed: 23488780
Emerg Infect Dis. 2020 Aug;26(8):1933-1935
pubmed: 32339092
J Infect Dis. 2018 Feb 14;217(5):759-766
pubmed: 29216358
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Emerg Infect Dis. 2020 Aug;26(8):1928-1930
pubmed: 32339091
Clin Infect Dis. 2020 Feb 05;:
pubmed: 32020174
Int J Public Health. 2010 Oct;55(5):459-68
pubmed: 20467882
N Engl J Med. 2020 May 28;382(22):2075-2077
pubmed: 32240582
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Nat Immunol. 2015 Jan;16(1):18-26
pubmed: 25521681
Clin Infect Dis. 2004 Jun 15;38(12):e123-5
pubmed: 15227635
Epidemiol Serv Saude. 2020 Apr 09;29(2):e2020128
pubmed: 32294755
Sci Rep. 2020 Mar 3;10(1):3963
pubmed: 32127629
Int J Tuberc Lung Dis. 2020 May 1;24(5):547-548
pubmed: 32398214
Proc Biol Sci. 2015 Dec 22;282(1821):20143085
pubmed: 26702035
Int J Tuberc Lung Dis. 2011 May;15(5):571-81
pubmed: 21756508
Lancet Glob Health. 2018 May;6(5):e514-e522
pubmed: 29580761
Clin Chest Med. 2013 Jun;34(2):191-204
pubmed: 23702170
J Wildl Dis. 2014 Jul;50(3):496-504
pubmed: 24779462
Nat Med. 2020 May;26(5):640-642
pubmed: 32273610
Lancet Infect Dis. 2016 Apr;16(4):395-6
pubmed: 26725447
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Viruses. 2013 Mar 05;5(3):777-91
pubmed: 23462708
Chest. 2007 Jun;131(6):1817-24
pubmed: 17400690
Emerg Infect Dis. 2004 May;10(5):818-24
pubmed: 15200814
J Clin Microbiol. 2019 Aug 26;57(9):
pubmed: 31142607
Biomed Res Int. 2013;2013:295327
pubmed: 23984336
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Med Microbiol Immunol. 2005 Jan;194(1-2):1-6
pubmed: 15118911
J Immunol. 2014 Jul 15;193(2):469-75
pubmed: 24994909
Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53
pubmed: 21221847
Eur Respir J. 2020 Jul 9;56(1):
pubmed: 32457198
Am J Respir Crit Care Med. 2012 Jan 15;185(2):206-12
pubmed: 22071329
Genes (Basel). 2019 Aug 29;10(9):
pubmed: 31470675
Influenza Other Respir Viruses. 2013 May;7(3):244-8
pubmed: 22817684
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Clin Pharmacokinet. 2016 Aug;55(8):907-23
pubmed: 26798032
Lancet Infect Dis. 2013 Sep;13(9):752-61
pubmed: 23891402
J Infect. 2013 Jun;66(6):475-86
pubmed: 23462597
PLoS Pathog. 2013 Mar;9(3):e1003205
pubmed: 23505369
J Infect Dis. 2007 Apr 1;195(7):1018-28
pubmed: 17330793
Vaccine. 2017 Mar 1;35(9):1299-1305
pubmed: 28169075
Sci Rep. 2018 Jul 31;8(1):11475
pubmed: 30065292
JAMA Netw Open. 2020 Apr 24;3(4):e208857
pubmed: 32330277
Fa Yi Xue Za Zhi. 2020 Feb;36(1):21-23
pubmed: 32198987
Lancet Infect Dis. 2020 Jun;20(6):641-642
pubmed: 32213333
Intervirology. 2017;60(1-2):53-55
pubmed: 28683463
Nat Rev Genet. 2016 May 17;17(6):333-51
pubmed: 27184599
Nat Rev Drug Discov. 2020 Mar;19(3):149-150
pubmed: 32127666
Clin Microbiol Rev. 2011 Jan;24(1):210-29
pubmed: 21233513
Influenza Other Respir Viruses. 2018 Sep;12(5):613-622
pubmed: 29768714
J Hepatol. 1996 Jan;24(1):48-51
pubmed: 8834024
J Biol Chem. 2020 Apr 10;295(15):4773-4779
pubmed: 32094225
PLoS One. 2017 Jul 7;12(7):e0180143
pubmed: 28686604
Cell. 2018 Aug 23;174(5):1277-1292.e14
pubmed: 30142345
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Antiviral Res. 2013 Nov;100(2):446-54
pubmed: 24084488
Int J Tuberc Lung Dis. 2020 May 1;24(5):544-545
pubmed: 32398212
PLoS One. 2015 Jun 15;10(6):e0129173
pubmed: 26076197
Infect Genet Evol. 2019 Aug;72:93-112
pubmed: 30508687
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
J Immunol. 2011 Sep 1;187(5):2222-32
pubmed: 21775682
Crit Care. 2013 Sep 27;17(5):240
pubmed: 24093433
Nat Rev Immunol. 2018 Sep;18(9):591-596
pubmed: 29872140
Lancet Infect Dis. 2020 Oct;20(10):1118
pubmed: 32311322
Eur Respir J. 2016 Dec;48(6):1751-1763
pubmed: 27836953
J Infect Dis. 1977 Aug;136(2):171-5
pubmed: 894076
Eur Respir J. 2019 Jun 5;53(6):
pubmed: 31023852
J Infect. 2011 Oct;63(4):300-7
pubmed: 21839113
Chembiochem. 2020 Mar 2;21(5):730-738
pubmed: 32022370
J Infect Dis. 2020 May 11;221(11):1775-1781
pubmed: 32179908
Eur J Immunol. 2013 Jun;43(6):1568-77
pubmed: 23456989
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Ann Intern Med. 2014 Mar 18;160(6):389-97
pubmed: 24474051
Rheumatology (Oxford). 2006 Jun;45(6):703-10
pubmed: 16418198
Eur Respir J. 2020 May 21;55(5):
pubmed: 32265307
J Rheumatol Suppl. 2014 May;91:24-31
pubmed: 24788997
Crit Care Med. 2012 May;40(5):1487-98
pubmed: 22511131
Int J Infect Dis. 2014 Dec;29:301-6
pubmed: 25303830
Am J Respir Crit Care Med. 2014 Jul 1;190(1):9-18
pubmed: 24713029
Clin Microbiol Rev. 2006 Oct;19(4):614-36
pubmed: 17041137
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1081-1086
pubmed: 29348203
Int J Infect Dis. 2015 Mar;32:135-7
pubmed: 25809769
Tuberc Respir Dis (Seoul). 2014 Feb;76(2):84-7
pubmed: 24624218
Int J Tuberc Lung Dis. 2020 Apr 1;24(4):364-366
pubmed: 32317058
Nature. 2020 Apr;580(7802):175
pubmed: 32242113
Infect Immun. 2002 Aug;70(8):4501-9
pubmed: 12117962
Nat Med. 2012 Oct;18(10):1525-30
pubmed: 22961107
Pulmonology. 2020 Jul - Aug;26(4):233-240
pubmed: 32411943
J Clin Rheumatol. 2015 Oct;21(7):346-8
pubmed: 26398460
J Infect. 2014 Dec;69(6):533-45
pubmed: 24975174
Pharmacotherapy. 2004 Dec;24(12):1732-47
pubmed: 15585441
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7582-7
pubmed: 17416679
J Infect. 2020 Aug;81(2):318-356
pubmed: 32333918
Vopr Virusol. 2008 Jul-Aug;53(4):9-13
pubmed: 18756809
Chest. 2020 Feb;157(2):293-309
pubmed: 31421114
Clin Infect Dis. 2014 Jul 15;59(2):166-74
pubmed: 24785230
PLoS One. 2016 Feb 05;11(2):e0148669
pubmed: 26849130
PLoS One. 2015 May 04;10(5):e0124122
pubmed: 25938466
J Biol Chem. 2012 Sep 28;287(40):33656-63
pubmed: 22810226
Curr Opin Pulm Med. 2020 May;26(3):208-214
pubmed: 32068577
PLoS One. 2013 Jul 19;8(7):e69390
pubmed: 23894466
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Infect. 2020 May;80(5):536-546
pubmed: 32097688
PLoS One. 2014 Aug 21;9(8):e105617
pubmed: 25144636
J Vet Diagn Invest. 2017 May;29(3):298-304
pubmed: 28363251
Biomed Environ Sci. 2003 Sep;16(3):246-55
pubmed: 14631830
Am J Infect Control. 2018 Jan;46(1):105-107
pubmed: 28893443
J Telemed Telecare. 2020 Jun;26(5):309-313
pubmed: 32196391
Expert Opin Drug Saf. 2015 Feb;14(2):295-303
pubmed: 25494485
Radiology. 2020 Aug;296(2):E55-E64
pubmed: 32191587
Lancet. 2015 Sep 5;386(9997):995-1007
pubmed: 26049252
BMJ Open. 2015 Apr 22;5(4):e006577
pubmed: 25903751
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Cal State J Med. 1919 Mar;17(3):85
pubmed: 18737838
Influenza Other Respir Viruses. 2011 Nov;5(6):e535-43
pubmed: 21682848
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Clin Infect Dis. 2003 Sep 15;37(6):857-9
pubmed: 12955652
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618764483
pubmed: 29562753
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
Cancer Cell. 2017 Jun 12;31(6):848-848.e1
pubmed: 28609660
Clin Infect Dis. 2005 Oct 1;41(7):e67-71
pubmed: 16142653
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):556-558
pubmed: 32553007
J Interferon Cytokine Res. 2010 Sep;30(9):643-52
pubmed: 20726789
World J Pediatr. 2020 Jun;16(3):223-231
pubmed: 32034659
Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):547-56
pubmed: 21792558
Immunol Lett. 2018 Jun;198:33-43
pubmed: 29635002
Int J Infect Dis. 2020 Mar;92S:S15-S25
pubmed: 32032752
Lancet Glob Health. 2018 May;6(5):e475-e476
pubmed: 29580762
Rheumatol Int. 2000 Dec;20(1):31-3
pubmed: 11149659
Lancet. 2003 Apr 19;361(9366):1319-25
pubmed: 12711465
J Exp Med. 2008 Jan 21;205(1):105-15
pubmed: 18158321
PLoS One. 2017 Aug 14;12(8):e0181414
pubmed: 28806423
Am J Respir Crit Care Med. 2012 May 15;185(10):1104-9
pubmed: 22323300
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
J Infect Dis. 2008 Oct 1;198(7):962-70
pubmed: 18710327
Postepy Dermatol Alergol. 2018 Aug;35(4):429-430
pubmed: 30206460
Lancet. 2009 Aug 8;374(9688):451-8
pubmed: 19643469

Auteurs

Catherine Wei Min Ong (CWM)

Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore.
These authors contributed equally.
Members of ESGMYC.
ORCID: 0000-0003-1103-0451

Giovanni Battista Migliori (GB)

Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy delia.goletti@inmi.it giovannibattista.migliori@icsmaugeri.it.
These authors contributed equally.
ORCID: 0000-0002-2597-574X

Mario Raviglione (M)

Centre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.
Global Studies Institute, University of Geneva, Geneva, Switzerland.

Gavin MacGregor-Skinner (G)

Dept of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.

Giovanni Sotgiu (G)

Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
ORCID: 0000-0002-1600-4474

Jan-Willem Alffenaar (JW)

Sydney Pharmacy School, University of Sydney, Sydney, Australia.
Westmead Hospital, Sydney, Australia.
Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia.
Members of ESGMYC.

Simon Tiberi (S)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
Members of ESGMYC.
ORCID: 0000-0002-0738-4276

Cornelia Adlhoch (C)

Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
European Centre for Disease Prevention and Control Public Health Emergency team co-authors.
ORCID: 0000-0002-8842-0469

Tonino Alonzi (T)

Translational Research Unit, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Sophia Archuleta (S)

Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Sergio Brusin (S)

Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
European Centre for Disease Prevention and Control Public Health Emergency team co-authors.

Emmanuelle Cambau (E)

AP-HP-Lariboisiere, Bacteriologie, Laboratory Associated to the National Reference Centre for Mycobacteria, IAME UMR1137, INSERM, University of Paris, Paris, France.
Members of ESGMYC.

Maria Rosaria Capobianchi (MR)

Laboratory of Virology, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Concetta Castilletti (C)

Laboratory of Virology, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Rosella Centis (R)

Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
ORCID: 0000-0002-8551-3598

Daniela M Cirillo (DM)

Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Members of ESGMYC.
ORCID: 0000-0001-6415-1535

Lia D'Ambrosio (L)

Public Health Consulting Group, Lugano, Switzerland.
ORCID: 0000-0002-7000-5777

Giovanni Delogu (G)

Università Cattolica Sacro Cuore, Roma, Italy.
Mater Olbia Hospital, Olbia, Italy.
Members of ESGMYC.

Susanna M R Esposito (SMR)

Pediatric Clinic, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy.

Jose Figueroa (J)

National Health Service, London, UK.

Jon S Friedland (JS)

St George's, University of London, London, UK.
Members of ESGMYC.
ORCID: 0000-0001-7789-9649

Benjamin Choon Heng Ho (BCH)

Tuberculosis Control Unit, Dept of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
ORCID: 0000-0002-9506-3738

Giuseppe Ippolito (G)

Scientific Direction, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Mateja Jankovic (M)

School of Medicine, University of Zagreb and Clinic for Respiratory Diseases, University Hospital Center Zagreb, Zagreb, Croatia.
Members of ESGMYC.
ORCID: 0000-0002-0171-764X

Hannah Yejin Kim (HY)

Sydney Pharmacy School, University of Sydney, Sydney, Australia.
Westmead Hospital, Sydney, Australia.
Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia.

Senia Rosales Klintz (S)

Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
European Centre for Disease Prevention and Control Public Health Emergency team co-authors.

Csaba Ködmön (C)

Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
European Centre for Disease Prevention and Control Public Health Emergency team co-authors.

Eleonora Lalle (E)

Laboratory of Virology, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Yee Sin Leo (YS)

National Centre for Infectious Diseases, Singapore.

Chi-Chiu Leung (CC)

Hong Kong Tuberculosis, Chest and Heart Diseases Association, Wanchai, Hong Kong, China.

Anne-Grete Märtson (AG)

Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
ORCID: 0000-0001-6478-1959

Mario Giovanni Melazzini (MG)

Scientific Direction, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.

Saeid Najafi Fard (S)

Translational Research Unit, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Pasi Penttinen (P)

Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
European Centre for Disease Prevention and Control Public Health Emergency team co-authors.
ORCID: 0000-0001-6929-1086

Linda Petrone (L)

Translational Research Unit, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Elisa Petruccioli (E)

Translational Research Unit, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

Emanuele Pontali (E)

Dept of Infectious Diseases, Galliera Hospital, Genova, Italy.

Laura Saderi (L)

Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
ORCID: 0000-0002-5131-9367

Miguel Santin (M)

Dept of Infectious Diseases, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Dept of Clinical Science, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Members of ESGMYC.
ORCID: 0000-0002-8474-3543

Antonio Spanevello (A)

Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como, Italy.

Reinout van Crevel (R)

Radboudumc Center for Infectious Diseases, Radboud Institute for Health Sciences, Radboudumc, Nijmegen, The Netherlands.
Centre for Tropical Medicine and Global Health, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
Members of ESGMYC.

Marieke J van der Werf (MJ)

Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
European Centre for Disease Prevention and Control Public Health Emergency team co-authors.
ORCID: 0000-0001-8021-1358

Dina Visca (D)

Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como, Italy.
ORCID: 0000-0003-2298-1623

Miguel Viveiros (M)

Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Lisbon, Portugal.
Members of ESGMYC.

Jean-Pierre Zellweger (JP)

TB Competence Centre, Swiss Lung Association, Berne, Switzerland.

Alimuddin Zumla (A)

Dept of Infection, Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.

Delia Goletti (D)

Translational Research Unit, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy delia.goletti@inmi.it giovannibattista.migliori@icsmaugeri.it.
Saint Camillus International University of Health and Medical Sciences, Rome, Italy.
Members of ESGMYC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins antituberculeux › Vaccin BCG › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Nidovirales › Infections à Coronaviridae › Infections à coronavirus › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à VIH › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Orthomyxoviridae › Influenzavirus A › Virus de la grippe A › Sous-type H1N1 du virus de la grippe A › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Grippe humaine › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Appareil respiratoire › Poumon › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Coronavirus du syndrome respiratoire du Moyen-Orient › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Syndrome respiratoire aigu sévère › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › Epidemic and pandemic viral infections: impact...
questionsmedicales.fr › Infection › Maladies virales › Epidemic and pandemic viral infections: impact...